| 04/26/20 | NBIX | Opicapone (NDA) | FDA decision on Opicapone as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes. |
| 04/25/20 | SNYNF, SNY | MenQuadfi (BLA) | FDA decision on MenQuadfi to prevent meningococcal meningitis |
| 04/17/20 | AZN.L, AZN | Trastuzumab deruxtecan (BLA) | FDA decision on Trastuzumab deruxtecan or treatment of patients with HER2-positive metastatic breast cancer |
| 04/04/20 | LLY | Empagliflozin/Iinagliptin/Metformin Triple Combination Tablet (NDA) | FDA decision on the triple combination tablet for adults with Type 2 Diabetes |
| 04/04/20 | BMY | Luspatercept (BLA) | FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia |
| 04/04/20 | XLRN | Luspatercept (BLA) | FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia |